Rationally designed approaches to augment CAR-T therapy for solid tumor treatment

Chimeric antigen receptor T cell denoted as CAR-T therapy has realized incredible therapeutic advancements for B cell malignancy treatment. However, its therapeutic validity has yet to be successfully achieved in solid tumors. Different from hematological cancers, solid tumors are characterized by d...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhu, Chaojie, Wu, Qing, Sheng, Tao, Shi, Jiaqi, Shen, Xinyuan, Yu, Jicheng, Du, Yang, Sun, Jie, Liang, Tingxizi, He, Kaixin, Ding, Yuan, Li, Hongjun, Gu, Zhen, Wang, Weilin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: KeAi Publishing 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10696433/
http://dx.doi.org/10.1016/j.bioactmat.2023.11.002

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10696433/
http://dx.doi.org/10.1016/j.bioactmat.2023.11.002

Ejemplares similares